1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United Kingdom >
  5. Nucleus Networks Acquires Hammersmith Medicines Research

M&A Deal Summary

Nucleus Networks Acquires Hammersmith Medicines Research

On August 4, 2025, Nucleus Networks acquired life science company Hammersmith Medicines Research

Acquisition Highlights
  • This is Nucleus Networks’ 1st transaction in the Life Science sector.
  • This is Nucleus Networks’ 1st transaction in the United Kingdom.

M&A Deal Summary
Date 2025-08-04
Target Hammersmith Medicines Research
Sector Life Science
Buyer(s) Nucleus Networks
Deal Type Add-on Acquisition

Target

Hammersmith Medicines Research

London, United Kingdom
Hammersmith Medicines Research is specialize in early clinical trials of study drugs for pharmaceutical and biotechnology companies. Hammersmith Medicines Research was founded in 1993 and is based in London, United Kingdom.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Nucleus Networks

Vancouver, British Columbia, Canada
Category Company
Sector Information Technology
DESCRIPTION

Nucleus Networks is a Managed IT Services provider. Nucleus Networks is based in Vancouver, British Columbia.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: United Kingdom M&A 1 of 1
Year: 2025 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal